Why is Sunrest Lifescie falling/rising?
As of 18-Sep, Sunrest Lifescience Ltd is priced at 44.30 with no change, having declined 9.78% over the past week and 16.34% over the past month, indicating significant underperformance compared to the Sensex, which has gained 1.67% in the same period. Despite increased investor interest, the stock remains below its moving averages, suggesting a bearish trend.
As of 18-Sep, Sunrest Lifescience Ltd is currently priced at 44.30, with no change in price (0.00%). The stock has underperformed significantly in recent periods, showing a decline of 9.78% over the past week and 16.34% over the past month. Despite today's performance indicating that it has outperformed its sector by 0.76%, the stock is trading below all its moving averages, which suggests a bearish trend. Additionally, there has been a notable increase in investor participation, with delivery volume rising by 288.89% compared to the 5-day average, indicating some renewed interest. However, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.Broader market context shows that while Sunrest Lifescience has struggled, the benchmark Sensex has gained 1.67% over the past week and 2.20% over the past month. This stark contrast highlights the stock's underperformance relative to the broader market, with a year-to-date decline of 13.98% compared to the Sensex's increase of 7.52%. The overall liquidity of the stock remains adequate for trading, but the persistent underperformance against the benchmark suggests that investors may be cautious about its future prospects.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
